Product
PD-1/PD-L1 blockade
1 clinical trial
1 indication
Indication
Metastatic Non-small Cell Lung CancerClinical trial
A Phase 1b/2 Trial of Dupilumab Given in Conjunction With PD-1 or PD-L1 Blockade in the Treatment of Relapsed/Refractory Metastatic NSCLCStatus: Recruiting, Estimated PCD: 2024-09-01